Skip to main content
Top
Published in: Virchows Archiv 2/2004

01-02-2004 | Case Report

Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components

Authors: Ji Shin Lee, Young Bog Kim, Kyung Whan Min

Published in: Virchows Archiv | Issue 2/2004

Login to get access

Abstract

Metaplastic mammary carcinoma with osteoclast-like giant cells is a rare neoplasm, and the histogenesis of this tumor remains controversial. A case of metaplastic mammary carcinoma with osteoclast-like giant cells in a 72-year-old woman is reported with p53 mutational analysis. Microscopically, the tumor was composed of a dominant sarcomatous stromal component containing osteoclast-like giant cells and a minor component of intraductal carcinoma. Immunostaining for p53 revealed strong positivity in both intraductal and sarcomatous components, but not in osteoclast-like giant cells. Mutational analysis of the p53 gene disclosed an identical point mutation in both intraductal and sarcomatous components, but not in osteoclast-like giant cells, indicating that both components share the same progenitor cells, and osteoclast-like giant cells represent a reactive infiltrate.
Literature
1.
go back to reference Chhieng C, Cranor M, Lesser ME, Rosen PP (1998) Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol 22:188–194CrossRefPubMed Chhieng C, Cranor M, Lesser ME, Rosen PP (1998) Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol 22:188–194CrossRefPubMed
2.
go back to reference Dalbagni G, Ren ZP, Herr H, Cordon-Cardo C, Reuter V (2001) Genetic alterations in TP 53 in recurrent urothelial cancer: a longitudinal study. Clin Cancer Res 7:2797–2801PubMed Dalbagni G, Ren ZP, Herr H, Cordon-Cardo C, Reuter V (2001) Genetic alterations in TP 53 in recurrent urothelial cancer: a longitudinal study. Clin Cancer Res 7:2797–2801PubMed
3.
go back to reference Harris AL (1990) Mutant p53: the commonest genetic abnormality human cancer? J Pathol 162:5–6PubMed Harris AL (1990) Mutant p53: the commonest genetic abnormality human cancer? J Pathol 162:5–6PubMed
4.
go back to reference Herrington CS, Tarin D, Buley I, Athanasou N (1994) Osteosarcomatous differentiation in carcinoma of the breast: a case of “metaplastic” carcinoma with osteoclasts and osteoclast-like giant cells. Histopathology 24:282–285PubMed Herrington CS, Tarin D, Buley I, Athanasou N (1994) Osteosarcomatous differentiation in carcinoma of the breast: a case of “metaplastic” carcinoma with osteoclasts and osteoclast-like giant cells. Histopathology 24:282–285PubMed
5.
go back to reference Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD (1994) Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219:332–341PubMed Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD (1994) Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219:332–341PubMed
6.
go back to reference Meis JM, Ordonez NG, Gallager HS (1987) Sarcomatoid carcinoma of the breast: an immunohistochemical study of six cases. Virchows Arch 410:415–421 Meis JM, Ordonez NG, Gallager HS (1987) Sarcomatoid carcinoma of the breast: an immunohistochemical study of six cases. Virchows Arch 410:415–421
7.
go back to reference Oberman HA (1987) Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 11:918–929PubMed Oberman HA (1987) Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 11:918–929PubMed
8.
go back to reference Tavassoli FA, Norris HJ (1986) Breast carcinoma with osteoclastlike giant cells. Arch Pathol Lab Med 110:636–639PubMed Tavassoli FA, Norris HJ (1986) Breast carcinoma with osteoclastlike giant cells. Arch Pathol Lab Med 110:636–639PubMed
9.
go back to reference Wada H, Enomoto T, Tsujimoto M, Nomura T, Murata Y, Shroyer KR (1998) Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis. Hum Pathol 29:1324–1328PubMed Wada H, Enomoto T, Tsujimoto M, Nomura T, Murata Y, Shroyer KR (1998) Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis. Hum Pathol 29:1324–1328PubMed
10.
go back to reference Wang X, Mori I, Tang W, Yang Q, Nakamura M, Nakamura Y, Sato M, Sakurai T, Kennichi K (2001) Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol 14:1183–1186PubMed Wang X, Mori I, Tang W, Yang Q, Nakamura M, Nakamura Y, Sato M, Sakurai T, Kennichi K (2001) Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol 14:1183–1186PubMed
11.
go back to reference Wargotz ES, Norris HJ (1989) Metaplastic carcinoma of the breast: III. Carcinosarcoma. Cancer 64:1490–1499PubMed Wargotz ES, Norris HJ (1989) Metaplastic carcinoma of the breast: III. Carcinosarcoma. Cancer 64:1490–1499PubMed
12.
go back to reference Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 21:1142–1150PubMed Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 21:1142–1150PubMed
Metadata
Title
Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components
Authors
Ji Shin Lee
Young Bog Kim
Kyung Whan Min
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 2/2004
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-003-0953-5

Other articles of this Issue 2/2004

Virchows Archiv 2/2004 Go to the issue